What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

Gaia Giannone, Andrea Milani, Elena Geuna, Danilo Galizia, Federica Biello, Filippo Montemurro

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)5-9
Number of pages5
JournalExpert Opinion on Pharmacotherapy
Volume20
Issue number1
DOIs
Publication statusPublished - Jan 2 2019

Keywords

  • adjuvant
  • breast cancer
  • chemotherapy
  • HER2
  • lapatinib
  • metastatic
  • neratinib
  • pertuzumab
  • T-DM1
  • trastuzumab

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer? / Giannone, Gaia; Milani, Andrea; Geuna, Elena; Galizia, Danilo; Biello, Federica; Montemurro, Filippo.

In: Expert Opinion on Pharmacotherapy, Vol. 20, No. 1, 02.01.2019, p. 5-9.

Research output: Contribution to journalEditorial

@article{9661cb5935394665af2f165b496ec4d1,
title = "What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?",
keywords = "adjuvant, breast cancer, chemotherapy, HER2, lapatinib, metastatic, neratinib, pertuzumab, T-DM1, trastuzumab",
author = "Gaia Giannone and Andrea Milani and Elena Geuna and Danilo Galizia and Federica Biello and Filippo Montemurro",
year = "2019",
month = "1",
day = "2",
doi = "10.1080/14656566.2018.1543406",
language = "English",
volume = "20",
pages = "5--9",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

AU - Giannone, Gaia

AU - Milani, Andrea

AU - Geuna, Elena

AU - Galizia, Danilo

AU - Biello, Federica

AU - Montemurro, Filippo

PY - 2019/1/2

Y1 - 2019/1/2

KW - adjuvant

KW - breast cancer

KW - chemotherapy

KW - HER2

KW - lapatinib

KW - metastatic

KW - neratinib

KW - pertuzumab

KW - T-DM1

KW - trastuzumab

UR - http://www.scopus.com/inward/record.url?scp=85056204203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056204203&partnerID=8YFLogxK

U2 - 10.1080/14656566.2018.1543406

DO - 10.1080/14656566.2018.1543406

M3 - Editorial

AN - SCOPUS:85056204203

VL - 20

SP - 5

EP - 9

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 1

ER -